Table 1.

Measures of Effect Size Using Ordinal and Utility-Weight Analysis of the Modified Rankin Scale

Trial	Median mRS Control	Median mRS Treatment	Delta mRS Medians	Mean mRS Control	Mean mRS Treatment	Delta mRS means	Mean Utility Control	Mean Utility Treatment	Delta Utility Means	95% CI
Hemicraniectomy Meta-Analysis	6	4	2	5.20	3.91	1.29	0.150	0.399	0.249	0.134 - 0.364
SWIFT	4	3	1	3.94	3.11	0.83	0.365	0.547	0.182	0.044 - 0.320
MR CLEAN	4	3	1	3.95	3.49	0.46	0.362	0.462	0.100	0.043 - 0.157
NINDS TPA Trials	3	2	1	3.19	2.66	0.53	0.501	0.591	0.089	0.031 - 0.149
TREVO 2	4	4	0	3.74	3.40	0.34	0.395	0.464	0.069	−0.042 - 0.180
MELT	3	3	0	3.07	2.59	0.48	0.516	0.583	0.067	−0.168 - 0.065
PROACT 2	4	3	1	3.60	3.28	0.32	0.434	0.481	0.047	−0.168 - 0.074
IMS 3	3	3	0	3.20	3.01	0.19	0.505	0.541	0.036	−0.024 - 0.097
IST 3	4	4	0	3.83	3.67	0.16	0.418	0.448	0.030	0.001 - 0.058
ECASS 3	2	1	1	2.20	1.99	0.21	0.674	0.700	0.026	−0.070 - 0.018
INTERACT 2	3	3	0	2.93	2.81	0.12	0.553	0.579	0.026	0.001 - 0.051